168 related articles for article (PubMed ID: 16424981)
1. The role of genetic markers--NAP1L1, MAGE-D2, and MTA1--in defining small-intestinal carcinoid neoplasia.
Kidd M; Modlin IM; Mane SM; Camp RL; Eick G; Latich I
Ann Surg Oncol; 2006 Feb; 13(2):253-62. PubMed ID: 16424981
[TBL] [Abstract][Full Text] [Related]
2. Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed.
Modlin IM; Kidd M; Latich I; Zikusoka MN; Eick GN; Mane SM; Camp RL
Ann Surg; 2006 Jul; 244(1):52-60. PubMed ID: 16794389
[TBL] [Abstract][Full Text] [Related]
3. Utility of molecular genetic signatures in the delineation of gastric neoplasia.
Kidd M; Modlin IM; Mane SM; Camp RL; Eick GN; Latich I; Zikusoka MN
Cancer; 2006 Apr; 106(7):1480-8. PubMed ID: 16502410
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
[TBL] [Abstract][Full Text] [Related]
5. Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1.
Kidd M; Modlin IM; Pfragner R; Eick GN; Champaneria MC; Chan AK; Camp RL; Mane SM
Cancer; 2007 Jun; 109(12):2420-31. PubMed ID: 17469181
[TBL] [Abstract][Full Text] [Related]
6. Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learning.
Drozdov I; Kidd M; Nadler B; Camp RL; Mane SM; Hauso O; Gustafsson BI; Modlin IM
Cancer; 2009 Apr; 115(8):1638-50. PubMed ID: 19197975
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.
Cheng CW; Liu YF; Yu JC; Wang HW; Ding SL; Hsiung CN; Hsu HM; Shieh JC; Wu PE; Shen CY
Ann Surg Oncol; 2012 Dec; 19(13):4129-39. PubMed ID: 22864797
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis.
Toh Y; Oki E; Oda S; Tokunaga E; Ohno S; Maehara Y; Nicolson GL; Sugimachi K
Int J Cancer; 1997 Aug; 74(4):459-63. PubMed ID: 9291440
[TBL] [Abstract][Full Text] [Related]
9. Different gene expression profiles in metastasizing midgut carcinoid tumors.
Edfeldt K; Björklund P; Åkerström G; Westin G; Hellman P; Stålberg P
Endocr Relat Cancer; 2011 Aug; 18(4):479-89. PubMed ID: 21636701
[TBL] [Abstract][Full Text] [Related]
10. Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease.
Kidd M; Modlin IM; Mane SM; Camp RL; Shapiro MD
Ann Surg; 2006 Feb; 243(2):273-80. PubMed ID: 16432362
[TBL] [Abstract][Full Text] [Related]
11. Metastasis-associated protein 1 nuclear expression is associated with tumor progression and clinical outcome in patients with non-small cell lung cancer.
Zhu X; Guo Y; Li X; Ding Y; Chen L
J Thorac Oncol; 2010 Aug; 5(8):1159-66. PubMed ID: 20661085
[TBL] [Abstract][Full Text] [Related]
12. Metastasis-associated protein 1 is a novel marker predicting survival and lymph nodes metastasis in cervical cancer.
Liu T; Yang M; Yang S; Ge T; Gu L; Lou G
Hum Pathol; 2013 Oct; 44(10):2275-81. PubMed ID: 23866297
[TBL] [Abstract][Full Text] [Related]
13. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
[TBL] [Abstract][Full Text] [Related]
14. MTA1 Is Up-regulated in Colorectal Cancer and Is Inversely Correlated with Lymphatic Metastasis.
Li J; Ye L; Sun PH; Satherley L; Hargest R; Zhang Z; Jiang WG
Cancer Genomics Proteomics; 2015; 12(6):339-45. PubMed ID: 26543080
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of the expression of the metastasis-associated gene 1 in human neoplastic tissue.
Hofer MD; Tapia C; Browne TJ; Mirlacher M; Sauter G; Rubin MA
Arch Pathol Lab Med; 2006 Jul; 130(7):989-96. PubMed ID: 16831056
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor and metastasis-associated protein-1 are frequently expressed in estrogen receptor negative/HER2 positive breast cancer.
Zhao L; Niu F; Shen H; Liu X; Chen L; Niu Y
Virchows Arch; 2016 Jun; 468(6):687-96. PubMed ID: 27026268
[TBL] [Abstract][Full Text] [Related]
17. Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies.
Martin MD; Hilsenbeck SG; Mohsin SK; Hopp TA; Clark GM; Osborne CK; Allred DC; O'Connell P
Breast Cancer Res Treat; 2006 Jan; 95(1):7-12. PubMed ID: 16244788
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas.
Toh Y; Kuwano H; Mori M; Nicolson GL; Sugimachi K
Br J Cancer; 1999 Apr; 79(11-12):1723-6. PubMed ID: 10206283
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between MTA1 expression and invasive and metastatic ability of cervical cancer cell].
Han XY; Qian HL; Yang JJ; Zhang XY; Fu M; Liang X; Lin C; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):678-83. PubMed ID: 22176993
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma.
Wang W; Yang ZL; Liu JQ; Yang LP; Yang XJ; Fu X
Tumori; 2014; 100(6):667-74. PubMed ID: 25688501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
